PXR1 Antibody

What is PXR1 and why is it important in research?

PXR1 refers to an isoform of the Pregnane X Receptor (PXR), also known as NR1I2 (nuclear receptor subfamily 1, group I, member 2). This 434 amino acid protein is a member of the Nuclear Receptor subfamily of the Nuclear Hormone Receptor family . PXR plays a critical role in the induction of genes involved in drug transport and metabolism, making it significant for pharmacological and toxicological research. It functions as a transcription factor that activates multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs, and endogenous compounds . Additionally, emerging research suggests PXR functions as an endobiotic receptor that regulates inflammatory responses, expanding its significance to immunological research .

How does PXR1 differ from PXR2 and other isoforms?

PXR1 (434 amino acids) and PXR2 (473 amino acids) represent the two basic isoforms of the PXR gene. The key structural difference is that PXR2 contains a 39 amino acid N-terminal extension compared to PXR1 . Scientific literature has documented at least six PXR1 isoforms (Swiss Protein Accession # 075469). When selecting antibodies, researchers should note that some antibodies cannot recognize the "B" isoforms, which exhibit a deletion of amino acids 1-55 (sequence MEVRP...FNVM) . This distinction becomes critical when designing experiments to study specific PXR variants.

What is the potential confusion between different PXR1 proteins in scientific literature?

An important clarification for researchers is that "PXR1" appears in scientific literature referring to two distinct proteins:

• The nuclear receptor isoform (NR1I2) involved in xenobiotic metabolism described above

• A peroxisome assembly gene related to peroxisome biogenesis disorders (PBDs), which is a human homologue of the yeast P. pastoris PAS8 gene

This nomenclature overlap can create confusion when conducting literature reviews. The peroxisomal PXR1 functions as a receptor for proteins with type-1 peroxisomal targeting signal (PTS1) and is associated with lethal recessive diseases caused by defects in peroxisome assembly . When reviewing literature or designing experiments, researchers should carefully distinguish which PXR1 protein is being referenced.

What are the validated applications for PXR1 antibodies in current research?

Based on comprehensive validation studies, PXR1 antibodies have demonstrated effectiveness across multiple experimental applications:

When designing experiments, researchers should select antibodies that have been specifically validated for their intended application . For novel applications, preliminary validation studies are strongly recommended.

How should researchers optimize Western blot protocols for PXR1 detection?

For optimal Western blot results when detecting PXR1:

• Sample preparation: Use appropriate lysis buffers containing protease inhibitors to prevent degradation of PXR1 protein.

• Loading control selection: When studying nuclear receptors like PXR1, consider using nuclear-specific loading controls such as Lamin B rather than just housekeeping proteins.

• Expected molecular weight: Look for bands at 45-50 kDa, which corresponds to the observed molecular weight of PXR1, compared to its calculated weight of 50 kDa .

• Antibody dilution: Optimal dilutions should be determined experimentally for each laboratory's specific conditions, as sensitivity can vary between antibody lots and detection systems.

• Cross-reactivity considerations: Select antibodies with validated specificity for human, mouse, or rat PXR1 based on your experimental model .

Researchers should note that post-translational modifications may affect the apparent molecular weight of PXR1 in Western blot applications.

What species reactivity should be considered when selecting PXR1 antibodies?

When selecting PXR1 antibodies, species reactivity is a critical consideration:

What are the key considerations for immunohistochemistry experiments with PXR1 antibodies?

For successful immunohistochemistry experiments using PXR1 antibodies:

• Fixation protocol: Overfixation can mask epitopes; optimize fixation times based on tissue type.

• Antigen retrieval: Heat-induced epitope retrieval methods are generally more effective for nuclear receptors like PXR1.

• Blocking strategy: Due to PXR1's role in xenobiotic metabolism, consider tissue-specific blocking strategies, particularly in liver samples where expression is high.

• Controls: Include both positive controls (tissues known to express PXR1, such as liver) and negative controls (tissues with minimal expression or antibody omission).

• Subcellular localization: PXR1 exhibits both cytoplasmic and nuclear localization depending on activation state; this dual localization pattern should be considered when interpreting results .

Publications have successfully used PXR1 antibodies in IHC applications across multiple tissue types, with at least three publications specifically validating this approach .

How can researchers effectively study PXR1-RXR heterodimerization?

PXR1 forms a heterodimer with Retinoid X Receptor (RXR) as part of its functional mechanism . To study this interaction:

• Co-immunoprecipitation (Co-IP): Use PXR1 antibodies to pull down the protein complex, then probe for RXR to confirm interaction. This approach has been validated in published research .

• Proximity ligation assays (PLA): This technique can visualize protein-protein interactions in situ with high sensitivity.

• FRET/BRET analyses: These techniques allow for real-time monitoring of protein interactions in living cells.

• Mammalian two-hybrid systems: Useful for mapping interaction domains between PXR1 and RXR.

When designing experiments to study heterodimerization, researchers should consider that binding ligands such as pregnanolone can affect the interaction dynamics between PXR1 and RXR .

What are the methodological approaches for investigating PXR1's role in drug metabolism pathways?

To investigate PXR1's role in drug metabolism:

• Reporter gene assays: Construct reporter plasmids containing PXR1 response elements to measure transcriptional activation in response to different compounds.

• ChIP-seq analysis: Identify genome-wide binding sites of PXR1 to elucidate its direct target genes.

• Gene expression analysis: Combine PXR1 activation/inhibition with RNA-seq to identify regulated pathways.

• Knockout/knockdown studies: Several publications have utilized PXR1 knockout or knockdown approaches to assess the functional significance of this receptor in drug metabolism .

• Mass spectrometry-based proteomics: Identify changes in the protein interactome of PXR1 under different conditions.

Researchers investigating drug metabolism should note that PXR1 modulates drug transport and metabolism through regulation of target genes responsible for the transport and conversion of chemicals into metabolites that are more easily eliminated from the body .

How does post-translational modification affect PXR1 function and antibody recognition?

Recent research has identified several important post-translational modifications (PTMs) of PXR1 that affect its function:

• Poly(ADP-ribosyl)ation: This modification has been shown to be a critical regulator of acetaminophen-induced liver injury, as evidenced by research focusing on poly(ADP-ribosyl)ated PXR1 .

• Phosphorylation: Multiple phosphorylation sites can alter PXR1's transcriptional activity and protein stability.

• SUMOylation: This modification can affect PXR1's nuclear localization and interaction with coregulators.

• Ubiquitination: Controls PXR1 protein turnover and degradation pathways.

When selecting antibodies, researchers should consider whether their experimental questions require detection of specific PTM states of PXR1. Some modifications may mask epitopes recognized by certain antibodies, potentially leading to false-negative results. For comprehensive studies of PXR1 function, combining antibodies that recognize different epitopes or specific modified forms may be necessary.

What are common issues in PXR1 antibody experiments and how can they be resolved?

When troubleshooting, researchers should systematically test each variable while maintaining appropriate controls. For nuclear receptors like PXR1, pay particular attention to subcellular fractionation quality when preparing samples.

How should researchers validate PXR1 antibody specificity for their particular application?

To validate PXR1 antibody specificity:

• Positive controls: Include samples known to express PXR1 (e.g., liver tissue or hepatocyte cell lines).

• Negative controls: Use tissues or cells with minimal PXR1 expression, or ideally, PXR1 knockout models.

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide to confirm signal specificity.

• siRNA/shRNA knockdown: Verify reduced signal following PXR1 knockdown.

• Orthogonal detection methods: Confirm findings using alternative antibodies targeting different epitopes or using non-antibody-based methods.

Antibody validation is particularly important for PXR1 due to the existence of multiple isoforms and potential cross-reactivity with related nuclear receptors. Some antibodies specifically cannot recognize the "B" isoforms which show a deletion of amino acids 1-55 , which could lead to misleading results if these isoforms are present in your experimental system.

How is PXR1 implicated in cancer research and what methodological approaches are most effective?

PXR1 has emerging significance in cancer research, with studies demonstrating its involvement in various cancer types:

• Colon cancer: Research has shown that PXR suppresses proliferation and tumorigenicity of colon cancer cells , suggesting a tumor-suppressive role in this context.

• Hepatocellular carcinoma: Studies have investigated the interaction between Hepatitis B Virus X protein and PXR, showing enhanced synergistic effects with aflatoxin B1 in promoting hepatocarcinogenesis .

• Intrahepatic cholangiocarcinoma: PXR has been implicated in hepatitis B virus-related intrahepatic cholangiocarcinoma that originates from hepatocytes .

For effective cancer research involving PXR1, researchers should consider:

• Immunohistochemical analysis of PXR1 expression in tumor versus normal tissue

• Correlation of PXR1 expression/activity with clinical outcomes

• Functional studies using overexpression or knockdown approaches in cancer cell lines

• Investigation of PXR1 target genes in the context of tumor microenvironment

What are the considerations for using PXR1 antibodies in multiplex immunofluorescence studies?

For successful multiplex immunofluorescence studies with PXR1 antibodies:

• Antibody compatibility: Select primary antibodies from different host species to avoid cross-reactivity.

• Sequential staining: Consider sequential rather than simultaneous staining when using multiple rabbit antibodies.

• Spectral separation: Ensure fluorophores have sufficient spectral separation to avoid bleed-through.

• Controls: Include single-stained controls to verify specificity and confirm absence of unexpected cross-reactivity.

• Optimization: PXR1 shows both cytoplasmic and nuclear localization; optimize fixation and permeabilization to maintain this dual localization pattern.

Multiplex staining can be particularly valuable for studying PXR1 interactions with its heterodimeric partner RXR or for examining its relationship with target genes in specific cell types within complex tissues.

How can new antibody technologies advance PXR1 research?

Emerging antibody technologies offer new opportunities for PXR1 research:

• Single-domain antibodies (nanobodies): These smaller antibody fragments may provide better access to conformational epitopes in PXR1, particularly when studying protein-protein interactions.

• Recombinant antibody engineering: Custom-designed antibodies with enhanced specificity for particular PXR1 isoforms could resolve current limitations in isoform-specific detection.

• Intrabodies: Antibodies designed for intracellular expression could enable real-time monitoring of PXR1 localization and interactions in living cells.

• Proximity-labeling antibodies: These could help identify novel PXR1 interaction partners through biotinylation of proximal proteins.

• Bi-specific antibodies: These could be valuable for studying PXR1 in complex with other proteins, such as its heterodimeric partner RXR.

As computational methods for antibody design continue to advance, researchers can anticipate more precisely targeted tools for studying specific aspects of PXR1 biology .

What methodological advances are needed to better understand PXR1's role in inflammatory regulation?

To advance understanding of PXR1's emerging role as an endobiotic receptor that regulates inflammatory responses , several methodological approaches are needed:

• Cell-type specific conditional knockouts: To distinguish direct from indirect effects of PXR1 on inflammatory pathways.

• High-resolution imaging: To track PXR1 translocation during inflammatory responses in real-time.

• Single-cell transcriptomics: To identify cell-specific responses to PXR1 activation in inflammatory contexts.

• Humanized mouse models: To better translate findings across species, given the species-specific aspects of PXR1 function.

• Systems biology approaches: To integrate transcriptomic, proteomic, and metabolomic data for comprehensive understanding of PXR1's role in inflammation regulation.

This emerging research area represents an important expansion beyond PXR1's classical role in xenobiotic metabolism, potentially opening new therapeutic avenues for inflammatory conditions.